Related Experiment Video
Updated: Jul 19, 2025
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
AARDVARK: an automated reversion detector for variants affecting resistance kinetics
Thaidy Moreno1, Joaquin Magana2, David A Quigley1,3,4
1Department of Urology, UCSF, San Francisco, CA 94158, United States.
Bioinformatics (Oxford, England)
|August 16, 2023
Summary
A new R package, AARDVARK, automates the identification of reversion mutations. This advances the analysis of tumor sequence data for drug resistance mechanisms.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Research
Background:
- Tumor cells can develop resistance to FDA-approved therapies targeting DNA repair deficiencies.
- This resistance is often mediated by reversion mutations that restore DNA repair function.
- Current methods for identifying these mutations are manual and time-consuming.
Purpose of the Study:
- To develop an automated tool for identifying reversion mutations in tumor DNA sequence data.
- To streamline the analysis of mechanisms underlying therapeutic resistance in cancer.
Main Methods:
- Development of AARDVARK, an R package.
- Implementation of algorithms for automatic detection of reversion mutations.
- Utilizes DNA sequence data from patient tumors.
Main Results:
- AARDVARK automates the identification of reversion mutations.
- Reduces the need for manual annotation of sequence data.
- Facilitates faster analysis of drug resistance.
Conclusions:
- AARDVARK provides an efficient solution for identifying reversion mutations.
- This tool can accelerate research into cancer therapy resistance.
- Enables more effective personalized treatment strategies.
